{"id":263100,"date":"2026-09-23T10:00:09","date_gmt":"2026-09-23T04:30:09","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263100"},"modified":"2026-09-23T10:00:09","modified_gmt":"2026-09-23T04:30:09","slug":"amanta-healthcare-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/amanta-healthcare-best-stock-in-its-sector\/","title":{"rendered":"Is Amanta Healthcare the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Amanta Healthcare CMP Rs 186 (23 Sep 2026). Market cap Rs 718 Cr. ROE 7.46%. P\/E 48.94x versus Industry P\/E 51.81x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Amanta Healthcare is one of the names investors compare when screening the Healthcare sector, built on a 7.46% return on equity and a P\/E of 48.94x against an Industry P\/E of 51.81x. Whether Amanta Healthcare is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Amanta Healthcare<\/a> the best stock in its sector? The stock trades on the NSE at Rs 186 as of 23 September 2026, within its 52-week range of Rs 92.00 to Rs 209.95. Amanta Healthcare Ltd manufactures sterile intravenous fluids and injectable pharmaceutical formulations.<\/p>\n

Amanta Healthcare sits in the Healthcare sector, and its 7.46% ROE and 48.94x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n